PIUR IMAGING Secures €5.6M to Revolutionize AI-Powered Tomographic 3D Ultrasound Diagnostics

PIUR IMAGING GmbH, an innovative Austrian medtech company, is excited to announce the successful raise of €5,600,000 in its latest funding round. This remarkable achievement marks a significant milestone for a company dedicated to enhancing diagnostic ultrasound imaging through cutting-edge technology. Specializing in the acquisition and visualization of 3D ultrasound images, PIUR IMAGING is poised to redefine healthcare accessibility by enabling high-quality, affordable diagnostics through artificial intelligence and advanced tomographic ultrasound solutions. At the heart of the company’s breakthrough is its flagship product, PIUR tUS Infinity. This unique solution transforms any standard ultrasound system into a state-of-the-art 3D imaging device capable of producing high-resolution tomographic images with any conventional 2D ultrasound transducer. Unlike traditional ultrasound methods that require immediate image assessment, PIUR tUS Infinity allows physicians to capture entire 3D volumes of structures or organs, which can be retrospectively analyzed at any point in time. This capability, combined with sophisticated AI-driven analysis tools optimized specifically for thyroid and nodule evaluation, not only reduces operator dependency but also streamlines diagnostic workflows for improved patient outcomes. The newly secured funding will accelerate the development and global dissemination of the PIUR tUS Infinity system, further solidifying PIUR IMAGING’s role as the sole vendor-independent tomographic 3D ultrasound solution in the market. By leveraging these funds, the company aims to expand its research, refine its innovative products, and partner with healthcare providers to enhance diagnostic precision. PIUR IMAGING remains committed to its vision of democratizing access to high-quality healthcare, making state-of-the-art diagnostic tools available everywhere, and paving the way for a new era in ultrasound imaging diagnostics.